
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Evgen Pharma Plc | LSE:EVG | London | Ordinary Share | GB00BSVYN304 | ORD 0.25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.0% | 1.70 | 1.60 | 1.80 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1.70 | 1.70 | 1.70 | 6,650 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 422k | -4.04M | -0.0147 | -1.16 | 4.67M |
Date | Time | Source | Headline |
---|---|---|---|
13/11/2023 | 07:00 | RNSNON | Evgen Pharma PLC Upcoming conferences |
31/10/2023 | 14:38 | ALNC | ![]() |
31/10/2023 | 07:00 | UKREG | Evgen Pharma PLC Half-year Report |
26/10/2023 | 06:00 | RNSNON | Evgen Pharma PLC Erasmus Medical Center begins glioblastoma studies |
19/10/2023 | 18:39 | ALNC | ![]() |
19/10/2023 | 13:26 | RNSNON | Evgen Pharma PLC Authored Article Publication |
05/9/2023 | 13:22 | ALNC | ![]() |
05/9/2023 | 06:00 | UKREG | Evgen Pharma PLC Directorate Changes |
15/8/2023 | 09:01 | ALNC | ![]() |
15/8/2023 | 06:00 | UKREG | Evgen Pharma PLC Final Report from Phase 1b PK/PD study |
1 Year Evgen Pharma Chart |
Intraday Evgen Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |